Dr. Colleen Renee Macinnis, MD

Dr. Macinnis practices at Macinnis Dermatology in Leesburg, Florida.

Dr. Macinnis' NPI, 1700828290, was assigned on June 11, 2006. Dr. Macinnis graduated from OU College of Medicine in 1998. Dr. Macinnis holds Florida license ME100399.

Dr. Macinnis' primary practice is Macinnis Dermatology, at 27950 Us-27, Leesburg, FL 34748 in Lake County. The practice phone is (352) 350-5230.

Dr. Macinnis' primary practice is Macinnis Dermatology in Leesburg, Florida. The medical group on file is MacInnis Dermatology. Dmand AI also links Dr. Macinnis to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Macinnis practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Macinnis' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Macinnis is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Macinnis' licenses on file in 2 states: Florida and Oklahoma.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Macinnis treats.

CMS data shows 304 Medicare services from Dr. Macinnis across 8 procedure codes in 2024, for 167 Medicare patients. Medicare paid $79,193 for them. Every service was in an office.

CMS counts 167 Medicare patients who saw Dr. Macinnis in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Macinnis' median patient age at 78, with 52% women.

In 2024, Dr. Macinnis wrote 316 Medicare Part D claims for 211 patients. 96% of them were for generic drugs. CMS names the drug for 234 of them, across 5 drugs with 11 or more claims each, at $2,898 in total drug cost. In 2023, CMS named 456 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Macinnis for performance year 2024, reported as part of a group. Dr. Macinnis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of melanoma (skin cancer) excision by Dr. Macinnis, more than 82% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Macinnis. Dr. Macinnis' most frequent co-authors are Kim L. Carlson-Sweet, MD and David R. Minor, MD.

CMS Open Payments shows 46 general payments to Dr. Macinnis from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $97.

Dmand AI lists 3 awards for Dr. Macinnis, most recently CMS Stage 1 EHR in 2013.

Dr. Macinnis graduated from OU College of Medicine in 1998. Dr. Macinnis is a member of AAD and ASDS.

Dr. Macinnis is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.